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The current treatment of Cl 2 -induced lung injury consists of alleviating hypoxemia by administration of supplemental oxygen and ␤ 2 -agonists and, in severe cases, when patients develop acute respiratory distress syndrome or acute lung injury (ALI), mechanical ventilation (3, 11) . Mice exposed to Cl 2 (400 ppm for 30 min) develop increased respiratory system resistance and airway responsiveness to aerosolized methacholine (assessed by FlexiVent) up to 6 days after exposure. Decreased Na ϩ -dependent alveolar fluid clearance across the distal lung epithelium was also present. These conditions were alleviated by postexposure administration of long-term ␤ 2 -agonists (32) . We have shown that exposure of rats and mice to Cl 2 decreases ascorbate and GSH in the lung epithelial lining fluid and tissue and causes extensive injury to the airway and alveolar epithelia, leading to compromised gas exchange (22, 33) . Rats pretreated with ascorbate, Desferal (deferoxamine mesylate USP), and N-acetylcysteine before exposure to Cl 2 do not become hypoxic and have significantly lower levels of albumin in their bronchoalvelolar lavage (BAL) than rats treated with saline alone (22) . In addition, postexposure administration of ascorbate and deferoxamine in mice exposed to lethal concentrations of Cl 2 (600 ppm for 45 min) decreased mortality fourfold (39) .
Recently, considerable attention has been focused on the ability of NO 2 Ϫ to prevent ischemia-reperfusion injury, which is mediated in part by reactive species generated during the reperfusion phase. It has been suggested that, during hypoxia, NO 2 Ϫ is reduced to nitric oxide (NO), thereby providing a source of NO at the ischemic tissue, which then protects against injury via its anti-inflammatory, antioxidant, and antiapoptotic effects (5, 7, 8, 13, 28, 31) ; additional salutatory effects of NO include inhibition of platelet and neutrophil adhesion to endothelial cells (20) and increased local blood flow by elevation of vessel cGMP levels. The mechanisms by which NO 2 Ϫ is reduced to NO remain under investigation, with oxygen-sensitive metalloproteins (e.g., hemoglobin, myoglobin, and xanthine oxidoreductase) proposed to play central roles (14) . Therapeutic effects of NO 2 Ϫ in the lung have been demonstrated in the context of reversing hypoxic vasoconstriction and pulmonary arterial hypertension (14) ; however, potential beneficial effects of systemic administration in the alleviation of ALI have not been investigated.
Here, we demonstrate that rats exposed to Cl 2 (400 ppm for 30 min) and returned to room air develop severe lung injury. Intraperitoneal injections of NO 2 Ϫ after Cl 2 exposure decreased BAL protein concentration, pulmonary edema, and severe lung airway injury assessed by quantitative morphology. To our knowledge, this is the first demonstration that systemic administration of small concentrations of NO 2 Ϫ , which is used for the treatment of cyanide poisoning in adults (2), mitigates ALI in vivo. Thus the results of this study complement previous findings documenting beneficial effects of NO 2 Ϫ in preventing injury following ischemia-reperfusion and highlight its potential as a novel therapeutic agent in ALI.
MATERIALS AND METHODS
Animals. Pathogen-free Sprague-Dawley male rats (200 -250 g; Harlan Laboratories, Indianapolis IN) were used for these studies. All procedures were approved by the University of Alabama at Birmingham Institutional Animal Care and Use Committee.
Exposure to Cl2. Rats were placed inside a cylindrical glass chamber and exposed to 400 ppm Cl2 for 30 min, as previously described (22) . At the end of the exposure, they were returned to room air, injected intraperitoneally with saline containing NO 2 Ϫ (1 mg/kg body wt, 200 -200 l of saline per injection; Fisher Chemicals, Pittsburgh, PA) at 10 min and 2, 4, and 6 h, and killed 6 or 24 h after exposure. Peripheral oxygen saturations were measured with a MouseOx Small Animal Oxymeter (STARR Life Sciences, Allison Park, PA) connected to a personal computer equipped with analysis software. The sensor was placed on the rat tail. Respiratory rates were measured by observation.
Lung histology and morphology. After the animal was killed and the chest was opened, the lungs were filled in situ very slowly with 10% formalin at a constant pressure of 25 cmH2O (ϳ8 ml); they were then removed en bloc and immersed in 10% formalin for 48 h. The left lung was trisected horizontally, and sections from its middle were processed for paraffin sectioning and staining with hematoxylin and eosin (12) . Images were recorded with an Olympus BX41 microscope with a Q-Color 3 digital camera using QCapture software (QImaging, Surrey, BC, Canada) and examined by two independent blinded reviewers, who scored them using the following criteria: 0 ϭ normal epithelium, consisting of intact ciliated and nonciliated cells; 1 ϭ loss of cilia, presence of inflammatory infiltrates, Ͻ10% of epithelium exfoliated; 2 ϭ Ͼ10% but Ͻ50% of epithelium exfoliated; 3 ϭ Ͼ50% but less than 75% of epithelium exfoliated; 4 ϭ Ͼ75% of epithelium exfoliated.
Assessment of apoptosis/necrosis by TUNEL. Paraffin-embedded lung tissues were deparaffinized with xylene and washed and rehydrated with ethanol, fixed with 4% formaldehyde in PBS, and processed for terminal deoxynucleotidyl (TdT)-mediated dUTP nick end labeling (TUNEL) using the DeadEnd Fluorometric TUNEL System (Promega, Madison, WI). Accordingly, they were permeabilized with proteinase K solution and incubated in a nucleotide mixture containing fluorescein-12-dUTP and TdT for 60 min according to the manufacturer's instructions. Nuclei were counterstained with 4=,6-diamidino-2-phenylindole. Green fluorescence (indicative of TUNEL) was visualized with an inverted high-resolution digital microscope (Eclipse TE-2000U, Nikon Instruments, Melville, NY). Average intensity of green fluorescence was determined by MetaMorph software (Universal Imaging, Downingtown, PA).
Measurements of isoprostanes and lung weights. Immediately after the lungs were perfused with PBS for removal of blood, the right lung was removed and frozen with liquid nitrogen. Phospholipids were extracted and subjected to alkaline hydrolysis in the presence of butylated hydroxytoluene to release F2-isoprostanes, which were quantified by GC/NICI-MS, as previously described (25) . The left lung was blotted, weighed (for determination of wet weight), placed in an oven at 70°C for 7 days, and then weighed again for determination of the dry weight.
Plasma NO 2 Ϫ measurement. Blood was collected via cardiac puncture into 1-ml syringes containing 1.5% (wt/vol) sodium citrate, 5 mM N-ethylmaleimide, and 100 M diethylenetriaminepentaacetic acid. The contents of the syringe were mixed and then centrifuged at 2,000 g for 90 s at 25°C, and plasma was collected and further stabilized with 1 mM N-ethylmaleimide and 100 M diethylenetriaminepentaacetic acid. NO 2 Ϫ concentrations were measured by a reductive (I 3 Ϫ ) chemiluminescence method, as previously described (21), and verified by acid-sulfanilamide-dependent scavenging.
Statistical analysis. Data were analyzed by one-way ANOVA followed by the Tukey-Kramer multiple-comparisons test. P Ͻ 0.05 was considered significant.
RESULTS

Physiological variables.
All rats were alive 24 h after Cl 2 exposure. Upon return to room air, they exhibited evidence of respiratory distress, with marked flaring of the nostrils during inspiration, depressed respiratory rate, and hypoxemia ( Fig. 1) . These variables returned to normal by 24 h after exposure. Intraperitoneal injections of NO 2 Ϫ did not accelerate the rate of recovery of these variables compared with saline ( Fig. 1 ). Exposure to Cl 2 increased the BAL protein at 6 and 24 h after exposure ( Fig. 2 ), although the value was significantly less at 24 h than at 6 h; injection of NO 2 Ϫ resulted in significantly lower BAL proteins at 6 and 24 h. Similarly, in rats exposed to Cl 2 , lung wet-to-dry weight ratios were significantly higher than normal at 6 h after exposure; however, the lung wet-to-dry weight ratios of Cl 2 -exposed rats injected with NO 2 Ϫ were considerably lower than those receiving saline and not different from air controls (Fig. 2) . To clear the lungs of blood (which could potentially confound the interpretation of our results), lungs were perfused via the pulmonary artery in situ with normal saline until they were clear of blood. Of course, it is possible that perfusion of the lungs may have increased their extravascular lung water. However, our values for control wet-to-dry weight ratios are similar to those we reported previously for nonperfused rat lungs (22) and to those reported by others (4), and lungs from all groups were perfused using identical conditions. These findings indicate that injections of NO 2 Ϫ prevented Cl 2 -induced injury to the alveolar epithelium and lung microvasculature. Injection of NO 2 Ϫ did not increase levels of NO 2 Ϫ in the rat plasma at 6 h after exposure: 4.9 Ϯ 0.9 and 3.7 Ϯ 1 (SE) pmol/mg protein in rats injected with saline (n ϭ 5) and NO 2 Ϫ (n ϭ 6), respectively (P ϭ 0.4).
Morphological assessment of airway and distal lung injury.
Rats exposed to air, injected with saline or NO 2 Ϫ , and killed 6 or 24 h later had normal airway lung morphology, as shown by the presence of ciliated cells, intact epithelial surfaces, and thin interstitial spaces, without interstitial cells or edema (Fig. 3) . All sections were TUNEL-negative (Fig. 3B) . In contrast, airways of saline-injected rats exposed to Cl 2 and killed 6 h later exhibited significant injury to their epithelial surfaces: in most sections, the epithelium had completely separated from its basement membrane, and the interstitial space was infiltrated by inflammatory cells (Fig. 4A) . These sloughed cells were TUNEL-positive (Fig. 4B) . On the other hand, airways of rats exposed to Cl 2 and injected with NO 2 Ϫ exhibited diminished injury, as shown by significantly fewer sloughed epithelia (Fig. 4C) . On the basis of the criteria outlined in MATERIALS AND METHODS, the average airway injury scores at 6 h after exposure were as follows (means Ϯ SE, n ϭ 3): 0 Ϯ 0 for air ϩ saline, 0 Ϯ 0 for air ϩ NO 2 saline, by ANOVA followed by Tukey-Kramer multiple-comparisons test (GraphPAD InStat Software)]. Significantly less green fluorescence was seen in the airway of Cl 2 -exposed rats injected with NO 2 Ϫ than in those treated with saline (Figs. 4D and 5), although in both cases, levels of green fluorescence were significantly higher than in the airways of rats exposed to room air (Fig. 5) .
To determine whether positive findings for TUNEL resulted from apoptotic or necrotic cells, we immunostained lung tissues with an antibody against the cleaved form of caspase-3 (catalog no. 9661, Cell Signaling Technology, Beverly, MA) at 4°C overnight and subsequently with a FITC-labeled secondary antibody (Sigma-Aldrich, St. Louis, MO). No significant amount of caspase-3 staining was observed in lung tissues of rats Fig. 1 . Breathing frequencies and peripheral oxygen saturations. Rats were exposed to 400 ppm Cl2 for 30 min, returned to room air, and killed 6 h (A and C) or 24 h (B and D) after exposure. All rats received intraperitoneal injections of NO 2 Ϫ (1 mg/kg body wt) or an equivalent amount of saline (50 l) at 0.1, 2, 4, and 6 h after exposure. Values are means Ϯ SE. A and B: breath rates (determined by observation). C and D: peripheral oxygen saturations. In A and C, n ϭ 8 air ϩ saline and air ϩ NO 2 Ϫ , n ϭ 7 Cl2 ϩ saline, n ϭ 9 Cl2 ϩ NO 2 Ϫ ; in B and D, n ϭ 3 air ϩ saline and air ϩ NO 2 Ϫ , n ϭ 6 Cl2 ϩ saline and Cl2 ϩ NO 2 Ϫ . Breathing frequencies and oxygen saturations for Cl2 ϩ saline and Cl2 ϩ NO 2 Ϫ at all time points, except 24 h after exposure, are significantly different from their corresponding control values (1-way ANOVA followed by Tukey-Kramer multiple-comparisons test).
Fig. 2. NO 2
Ϫ decreases protein levels in bronchoalveolar lavage (BAL) and bloodless lung wet-to-dry weight ratios. Rats were exposed to 400 ppm Cl2 for 30 min, returned to room air, and killed 6 or 24 h after exposure. All rats received intraperitoneal injections of NO 2 Ϫ (1 mg/kg body wt) or an equivalent amount of saline (200 -250 l) at 0.1, 2, 4, and 6 h after exposure. At 6 or 24 h after exposure, they were killed and their lungs were lavaged with 8 ml of normal saline, which was instilled and withdrawn slowly 3 times; BAL samples were spun at 300 g for 10 min at 4°C to pellet cells (22) . A: protein concentrations in cell-free BAL measured using the bicinchoninic acid (BCA) Protein Assay Reagent Kit (Pierce, Rockford, IL) and as previously described (17) . B: blood-free lung wet-to-dry weight (W/D) ratios. Values are means Ϯ SE; n ϭ 8 air ϩ saline, n ϭ 2 air ϩ NO 2 Ϫ , n ϭ 7 Cl2 ϩ saline, n ϭ 10 Cl2 ϩ NO 2 Ϫ at 6 h; n ϭ 3 air ϩ NO 2 Ϫ , n ϭ 6 Cl2 ϩ saline and Cl2 ϩ NO 2 Ϫ at 24 h; for wet-to-dry lung weights, n ϭ 4 for each group. *P Ͻ 0.05 vs. corresponding air value (ANOVA followed by Tukey's t-test for multiple comparisons). #P Ͻ 0.05 vs. corresponding saline value (2-tailed t-test) .^P Ͻ 0.05 vs. corresponding saline value (1-tailed t-test).
exposed to Cl 2 and injected with saline or NO 2 Ϫ (data not shown). The results of these studies indicate that most of the TUNEL staining was the result of necrosis of airway epithelial cells.
Focal areas of alveolar consolidation and inflammation were also observed, and some contained cellular exudates (data not shown), as previously reported. Alveolar injury, although present, was less extensive than airway injury, in agreement with our previous findings (22) . However, the increased amount of protein in the BAL, as well as injury to pulmonary surfactant and ion transport of distal lung epithelia of rats and mice exposed to 400 ppm Cl 2 (22, 33) , indicate that, at these concentrations, Cl 2 or its reactive intermediates damage airway and distal lung epithelia.
There was considerable variability in the extent of injury in the airways of rats 24 h after exposure to Cl 2 . Focal areas of extensive injury, with denuded airway epithelia and extensive injury to the underlying structures, were present in all sections. However, there were numerous areas where the appearance of the airway epithelium was consistent with the presence of repair (Fig. 6C) . These sections were TUNEL-negative. 
Mechanistic insights: number of cells in BAL and F 2 -isoprostanes. A possible mechanism by which NO 2
Ϫ may diminish lung injury is to decrease the influx of inflammatory cells in the BAL and lung tissue. As shown in Fig. 7 , exposure to Cl 2 resulted in a significant increase in the number of cells in the BAL at 6 and 24 h after exposure mainly due to the influx of neutrophils. Injection of NO 2 Ϫ did not decrease neutrophils in the BAL. Similarly, lung tissue myeloperoxidase activity [measured as previously described (1)] of saline-and NO 2 Ϫ -injected rats exposed to Cl 2 was elevated to the same extent (data not shown). These data indicate that protective effects of NO 2 Ϫ are not due to decreased levels of inflammatory cells in the lung tissue or BAL.
In our next series of experiments, we measured levels of F 2 -isoprostanes, a group of prostaglandin F 2 -like compounds derived from the nonenzymatic oxidation of arachidonic acid (25) in lung tissues of rats at 6 and 24 h after Cl 2 exposure. As shown in Fig. 8 , exposure to Cl 2 increased F 2 -isoprostanes in lung tissue by 2.5-fold, and values remained elevated at 6 h after exposure. Administration of NO 2 Ϫ did not affect the F 2 -isoprostane levels, indicating that its protective effect was not mediated by preventing lipid peroxidation.
DISCUSSION
Cl 2 gas exposure results in significant postexposure toxicity to the lungs, leading to ALI and acute respiratory distress syndrome. The risk for Cl 2 exposure in a mass-casualty situation, therefore, has led to an interest in developing targeted therapeutics that can be administered after exposure to limit lung injury. With this goal in mind, we tested the potential of NO 2 Ϫ , which has been the subject of recent interest as a therapy to replenish NO bioactivity in diseases characterized by ischemia and inflammation.
The Cl 2 exposure regimens used in this study were chosen to approximate levels encountered in the vicinity of industrial accidents. For example, Weill et al. (37) reported 400 ppm Cl 2 within 75 yards of accidental spills of Cl 2 from rail cars. Ten of the exposed individuals were hospitalized with pulmonary edema. In another report, 23 of 418 patients exposed to Cl 2 during a chemical spill were hospitalized with pulmonary edema (11) . Our previous data indicate that exposure of rats and mice to 400 ppm Cl 2 for 30 min results in extensive injury to alveolar epithelial compartments, as evidenced by arterial Ϫ -injected animals exposed to Cl2. Rats were exposed to Cl2 (400 ppm for 30 min), returned to room air, and killed 6 h after exposure. They received injections of NO 2 Ϫ or saline. Average intensity of green fluorescence levels in main bronchus images (see Fig. 4 ) was calculated using Metamorph imaging software by 2 different investigators who were blinded regarding the groups of the rats. Five images were obtained for each rat, which were averaged so that each rat was weighted equally. Values are means Ϯ SE; n ϭ 3 rats in each group. *P Ͻ 0.001 vs. corresponding control value. #P Ͻ 0.001 vs. corresponding saline value in the same group. Fig. 6 . Airway sections of rats exposed to Cl2 and killed 24 h after exposure. Rats were exposed to 400 ppm Cl2 for 30 min, returned to room air, injected with saline (A and B) or NO 2 Ϫ (C and D), and killed 24 h after exposure. A and C: hematoxylin-and-eosin-stained sections of proximal airways. Note absence of epithelium in saline-injected rat (A) and presence of pseudostratified epithelium, indicating onset of repair, in NO 2 Ϫ -injected rat. Only background levels of green fluorescence were seen in the adjoining sections (B and D) processed for TUNEL, indicating the absence of necrotic/apoptotic cells. Approximately 5 sections were examined from each rat (n ϭ 3) with similar results. Scale bar, 50 m.
hypoxemia, increased concentrations of protein in the BAL, compromised alveolar fluid clearance and surfactant function, and decreased levels of low-molecular-weight scavengers in the BAL and lung tissues (22, 33, 34, 38) .
Data presented in the present study document the presence of significant neutrophilia and extensive necrosis of airway epithelia and inflammation and edema, as indicated by increased levels of neutrophils and protein in the BAL. Interestingly, as shown in Fig. 2 , at 24 h after exposure, BAL protein levels decreased from their peak values, suggestive of tissue repair. Similarly, the hypoxemia that is prevalent immediately after Cl 2 gas exposure recovers close to baseline levels by 6 h. Previous measurements of arterial PO 2 in rats exposed to 400 ppm Cl 2 for 30 min and returned to room air for 24 h were consistent with the presence of arterial hypoxemia, corresponding to an oxygen saturation of ϳ90%, similar to that found in this study (22) , within the experimental error of the measurements. Importantly, however, and despite improvement in indexes of oxygenation, lung permeability, and inflammation within 24 h of exposure, emerging data show that long-term pulmonary dysfunction occurs (observed over several days after Cl 2 exposure), as evidenced by the development of reactive airway syndrome (23, 35) and decreased pulmonary function (19, 29) . This further underscores the need for a better understanding of the mechanisms that mediate post-Cl 2 exposure lung injury and development of targeted postexposure therapies that can prevent secondary injury and/or facilitate repair.
Our data show significant bronchiolar deepithelialization and loss of basement membrane, with accumulation of TUNEL-positive cells and debris, within 6 h after Cl 2 exposure. Paralleling this are increased levels of F 2 -isoprostanes, stable markers of lipid peroxidation (25) . Interestingly, however, lung F 2 -isoprostane levels were generated during Cl 2 exposure and did not increase further after Cl 2 exposure. At first glance, these data may suggest that propagating lipid peroxidation reactions do not continue beyond the initial exposure period and that Cl 2 itself and/or its hydrolysis product HOCl is likely the mediator of arachidonic acid oxidation. On the other hand, it is also possible that constant levels of F 2 -isoprostanes may reflect the presence of equilibrium between their rates of production and breakdown by the plateletactivating factor acetylhydrolase. HOCl is a potent oxidant and will react with multiple biological molecules, including amines, to produce chloramines (k ϳ10 5 M Ϫ1 ·s Ϫ1 , where k is the apparent second order rate constant) (26) . It is likely that the biological effects of HOCl could be at least partially attributed to effects of the chloramines (24, 27) , which are relatively long-lasting, and selective chlorinating species that remain after the cessation of Cl 2 exposure. Previously, we showed that that chloramines produced by the reaction of HOCl with glycine or taurine inhibit the activity of epithelial sodium channels (33) .
NO 2 Ϫ -mediated protection against inflammatory tissue injury is thought to occur primarily by its reduction to NO by reduced hemoglobin in hypoxic red blood cells, which in turn could affect ALI by several mechanisms, including modulation of leukocyte adhesion and infiltration, inhibition of endothelial/ epithelial cell permeability, prevention of cell death, and exertion of antioxidant effects (5, 7, 8, 13, 28, 31) . As shown in Fig. 1 , rats exposed to Cl 2 showed signs of moderate-to-severe hypoxemia immediately upon return to room air, in agreement with our previous findings (22) . However, oxygen saturations Ϫ in Cl2-exposed rats do not decrease the number of inflammatory cells in BAL. Rats were exposed to 400 ppm Cl2 for 30 min, returned to room air, and killed 6 or 24 h after exposure. All rats received intraperitoneal injections of NO 2 Ϫ (1 mg/kg body wt in 50 l of normal saline) or an equivalent amount of saline at 0.1, 2, 4, and 6 h after exposure. Values are means Ϯ SE; n ϭ 8 animals in 6-h group and 3 animals in 24-h group. *P Ͻ 0.05 vs. corresponding air values. Fig. 8 . Exposure to Cl2 increases F2-isoprostane (F2-IsoP) levels in lung tissues. Rats were exposed to 400 ppm Cl2 for 30 min, returned to room air, and killed 6 h after exposure. All rats received intraperitoneal injections of NO 2 Ϫ (1 mg/kg body wt in 50 l of normal saline) or an equivalent amount of saline at 0.1, 2, 4, and 6 h after exposure. Values are means Ϯ SE; n ϭ 8 in each group. *P Ͻ 0.05 vs. corresponding air values.
improved significantly during the next 6 h, reaching ϳ90%. For this reason, we decided to initiate NO 2 Ϫ injections as soon as possible upon return of Cl 2 -exposed rats to room air. Administration of NO 2 Ϫ after Cl 2 exposure, during the period that rats experienced moderate-to-severe hypoxemia, prevented pulmonary edema, indicated by inhibition of protein accumulation in BAL and maintenance of lung wet-to-dry weight ratios. Interestingly, NO 2 Ϫ did not affect BAL inflammatory cell accumulation, nor did NO 2 Ϫ alter F 2 -isoprostane levels. NO 2 Ϫ did, however, inhibit TUNEL-positive cells collectively, suggesting that NO 2 Ϫ protected against lung injury by modulating permeability and cell death, consistent with findings from a study of in vivo ischemia-reperfusion of heart and liver (8) .
The protective effects of NO 2 Ϫ were also evident in histological analysis of bronchial airways 6 h after exposure. Since NO 2 Ϫ was administered after exposure, it is not surprising that only partial (ϳ30%) protection was observed (Fig. 6) , with airways showing a phenotype intermediate to control animals and animals exposed to Cl 2 alone. Specifically, Cl 2 exposure resulted in a complete loss of epithelia and basement membrane, whereas in the NO 2 Ϫ -treated group, basement membrane, together with partial epithelium, was seen. The temporal and molecular mechanisms that regulate post-Cl 2 toxicity and repair are not well defined. The sites at which systemically administered NO 2 Ϫ acts to mitigate lung injury are not clear and require further investigation; without this information, it is difficult to assess more detailed molecular mechanisms of NO 2 Ϫ action. At relatively high doses, myeloperoxidase may catalyze the reaction on NO 2 Ϫ and hydrogen peroxide to form reactive nitrogen species (including nitrogen dioxide) (9, 10), which have the capacity to cause extensive injury to alveolar and airway targets (6, 15, 16) . In addition, high concentrations of NO 2 Ϫ in the plasma are likely to result in significant levels of methemoglobin, which will interfere with gas exchange. Different studies have reported that beneficial effects of NO 2 Ϫ supplementation in heart, liver, and brain ischemia-reperfusion injury are U-shaped, with protection being seen in the range of 48 -480 nmol [ϳ1.6 -16 nmol/g mouse body wt (with the assumption that mouse body weight is 30 g)] (8, 18) . In this study, we used a dose toward the higher end of this range (250 g nitrite/250-g rat, ϳ21 nmol/g body wt) and observed no increases in inflammatory injury, which would be observed with increased reactive nitrogen species, nor was hypoxemia made worse, suggesting that safe doses of NO 2 Ϫ can be administered.
In summary, we present evidence documenting that exposure of rats to Cl 2 , in concentrations likely to be encountered in the vicinity of industrial accidents, causes extensive injury to airway and alveolar epithelia that is at least partially reversed by the postexposure administration of small quantities of NO 2 Ϫ . Thus our data are in agreement with previous reports documenting the efficacy of NO 2 Ϫ to reduce systemic injury following oxidant stress and point to its potential importance as a new therapeutic agent in inhaled oxidant injury to the lungs.
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